CA2092565A1 - Compositions renfermant de l'ibuprofene et un diuretique - Google Patents

Compositions renfermant de l'ibuprofene et un diuretique

Info

Publication number
CA2092565A1
CA2092565A1 CA002092565A CA2092565A CA2092565A1 CA 2092565 A1 CA2092565 A1 CA 2092565A1 CA 002092565 A CA002092565 A CA 002092565A CA 2092565 A CA2092565 A CA 2092565A CA 2092565 A1 CA2092565 A1 CA 2092565A1
Authority
CA
Canada
Prior art keywords
ibuprofen
diuretic
effective amount
female
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002092565A
Other languages
English (en)
Inventor
Robert T. Sims
William Slivka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Publication of CA2092565A1 publication Critical patent/CA2092565A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002092565A 1990-09-28 1991-09-25 Compositions renfermant de l'ibuprofene et un diuretique Abandoned CA2092565A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58924290A 1990-09-28 1990-09-28
US589,242 1990-09-28

Publications (1)

Publication Number Publication Date
CA2092565A1 true CA2092565A1 (fr) 1992-03-29

Family

ID=24357215

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002092565A Abandoned CA2092565A1 (fr) 1990-09-28 1991-09-25 Compositions renfermant de l'ibuprofene et un diuretique

Country Status (5)

Country Link
EP (1) EP0550689A1 (fr)
JP (1) JPH06501475A (fr)
AU (1) AU8710691A (fr)
CA (1) CA2092565A1 (fr)
WO (1) WO1992005786A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462950A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
AU2013257715B2 (en) * 2012-05-08 2016-05-05 Cellixbio Private Limited Compositions and methods for suppression of carbonic anhydrase activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia

Also Published As

Publication number Publication date
EP0550689A1 (fr) 1993-07-14
JPH06501475A (ja) 1994-02-17
WO1992005786A1 (fr) 1992-04-16
EP0550689A4 (fr) 1994-02-16
AU8710691A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
US5164398A (en) Ibuprofen-antitussive combinations
EP0866713B1 (fr) Supports d'administration pour medicaments analgesiques, anti-inflammatoires et antipyretiques contenant de l'oxyde nitreux et compositions pharmaceutiques contenant ces supports et ces medicaments
US5374661A (en) Composition and method for transdermal delivery of diclofenac
CA2191129C (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
JP3305315B2 (ja) 動物及び人間の疼痛及び／又は炎症の抑制時における薬剤ならびにその製造及びその使用
US5260337A (en) Ibuprofen-muscle relaxant combinations
JP2002512194A (ja) 医原性および年齢関連性高血圧症の治療方法、およびこれに有用な医薬組成物
JP2002528498A (ja) 片頭痛の治療方法及び医薬組成物
CA1337930C (fr) Methode de traitement des blessures de la peau a l'aide d'antagonistes des recepteurs de la thromboxane a__
JPS61151125A (ja) ジヒドロコデイン／イブプロフエン薬剤組成物及び方法
JPH07507057A (ja) 解熱鎮痛方法および光学的に純粋なｒ（‐）ケトプロフェンを含有する組成物
JPS6341420A (ja) 鎮痛作用を有する医薬組成物
JPH11509547A (ja) Ｌ−ドーパエチルエステルの医薬組成品
JPS61197517A (ja) 薬剤組成物
EP0663839A1 (fr) Combinaisons d'ibuprofene-antihistaminique anti-h 2?
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
JP2834512B2 (ja) リポキシン誘導体を有効成分とする疾患治療剤
CA2092565A1 (fr) Compositions renfermant de l'ibuprofene et un diuretique
JPH0489428A (ja) 多形核白血球活性化剤
US20180125792A1 (en) Non-steroidal anti-inflammatory drugs for cough
EP0577757A1 (fr) Combinaisons d'ibuprofene et de decongestionnants
FR2500303A1 (fr) Le chlorure de gallium, nouveau medicament anti-cancereux
EP0551180B1 (fr) Utilisation de bucillamine pour la fabrication d'un médicament pour le traitement de la cystinurie
JPH05221857A (ja) 配合解熱鎮痛剤
CA2477391A1 (fr) Methode de traitement de l'osteoarthrite

Legal Events

Date Code Title Description
FZDE Dead